SUBSCRIBE
SUBSCRIBE
BioMidwest

Biologic Agent Reduces Ovarian Cancer Relapse Risk, Fox Chase Cancer Center Study

June 7, 2010 | 
1 min read

medPage Today -- CHICAGO -- Maintenance therapy with a targeted agent significantly reduced the risk of relapse in women with advanced ovarian and related cancers, a researcher said here.

MORE ON THIS TOPIC
Genetown
The Best Way to Answer Salary Interview Questions
June 11, 2024
 · 
4 min read
 · 
Lorenzo Soliman
Pictured: Man holding tablet computer with scienti
Job Trends
Life Sciences R&D, Manufacturing Talent Becoming More Difficult to Find: Report
June 6, 2024
 · 
3 min read
 · 
Greg Slabodkin
BioMidwest
Top 5 Companies Hiring in Illinois
May 29, 2024
 · 
1 min read
 · 
Angela Gabriel
Update: AbbVie headquarters building in California
Business
AbbVie Raises 2024 Profit Outlook, Reports Strong Q1 Sales for Skyrizi and Rinvoq
April 26, 2024
 · 
2 min read
 · 
Tyler Patchen